Home
Conditions
Epstein-Barr Virus Infections

Clinical trial condition

Epstein-Barr Virus Infections

Explore clinical trials studying Epstein-Barr Virus Infections. Study availability and eligibility vary by location and protocol.

692 public trials 114 recruiting studies

Refine in advanced search Browse all conditions

Epstein-Barr Virus Infections trial results

Completed

Vaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing Donor Stem Cell Transplant

NCT01588015

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +198 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Completed

Bortezomib and Gemcitabine in Treating Patients With Relapsed B-Cell Non-Hodgkin Lymphoma

NCT00863369

Conditions: Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +22 more
Locations: City of Hope Medical Center Duarte, California, United States

South Pasadena Cancer Center South Pasadena, California, United States

View Trial Details

Completed

TT52CAR19 Therapy for B-cell Acute Lymphoblastic Leukaemia (B-ALL)

NCT04557436

Conditions: B Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +19 more
Locations: Great Ormond Street Hospital London, United Kingdom

View Trial Details

Completed

Study of Efficacy and Safety of CTL019 in Pediatric ALL Patients

NCT02435849

Conditions: B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +19 more
Locations: Childrens Hospital Los Angeles SC CTL019 Los Angeles, California, United States

Stanford Universtiy Medical Center SC - CTL019B2205J - B2206 Stanford, California, United States

Children's Healthcare of Atlanta SC CTL019 Atlanta, Georgia, United States

University of Michigan . Ann Arbor, Michigan, United States

View all 23 locations

View Trial Details

Completed

Immune Responses to COVID-19 Vaccination in Lymphoma Patients

NCT04858568

Conditions: Burkitt Lymphoma, Chronic Disease, Chronic Lymphocytic Leukemia, +42 more
Locations: Bedfordshire Hospitals NHS Foundation Trust Bedford, Bedfordshire, United Kingdom

Portsmouth Hospitals University NHS Trust Portsmouth, Hampshire, United Kingdom

University Hospital Southampton NHS Foundation Trust Southampton, Hampshire, United Kingdom

Wye Valley NHS Trust Hereford, Herefordshire, United Kingdom

View Trial Details

Completed

A Study of Zilovertamab Vedotin (MK-2140) (VLS-101) in Participants With Hematologic Malignancies (MK-2140-001)

NCT03833180

Conditions: Acute Lymphoid Leukemia, Acute Myeloid Leukemia, Blood Protein Disorders, +49 more
Locations: City of Hope ( Site 0010) Duarte, California, United States

University of California - San Diego ( Site 0003) La Jolla, California, United States

UCLA Hematology & Oncology ( Site 0007) Los Angeles, California, United States

University of Nebraska Medical Center ( Site 0006) Omaha, Nebraska, United States

View all 14 locations

View Trial Details

Completed

Colony-Stimulating Factors to Relieve Neutropenia in Patients With Recurrent Non-Hodgkin's Lymphoma

NCT00004192

Conditions: Agranulocytosis, Blood Protein Disorders, Burkitt Lymphoma, +42 more
Locations: Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States

University of Nebraska Medical Center Omaha, Nebraska, United States

Ireland Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Monoclonal Antibody Therapy in Relapsed Non-Hodgkin's After Chemotherapy and Autologous Stem Cell Transplantation

NCT00031642

Conditions: Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +28 more
Locations: Eppley Cancer Center at University of Nebraska Medical Center Omaha, Nebraska, United States

View Trial Details

Completed

Combination Chemotherapy Plus Rituximab in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma

NCT00007865

Conditions: Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +28 more
Locations: University of Nebraska Medical Center, Eppley Cancer Center Omaha, Nebraska, United States

View Trial Details

Completed

Donor Peripheral Stem Cell Transplant in Treating Patients With Hematolymphoid Malignancies

NCT01523223

Conditions: Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), +82 more
Locations: Stanford University Stanford, California, United States

View Trial Details

Epstein-Barr Virus Infections

Epstein-Barr Virus Infections trial results

Related conditions